logo

Cancer

Share

Purdue University-based On Target Laboratories made a major breakthrough in terms of surgical innovations after the FDA approved its bio-illuminatory innovation for cervical cancer treatment. According to a report on Inside Indiana Business, the imaging agent, Cytalux targets cancer cells during...

Throughout the year, more and more cancer research has been moving towards automations for handling large amount of data and complex permutations. The process has went up a notch after tech giant Google (GOOGL) announced on Friday that it will be partnering with the United States National Cancer Institute...

People suffering from colorectal cancer are usually among the first ones to receive targeted therapies. These drugs block the cancer-causing proteins, which set off the out-of-control cell growth even while not impacting the healthy tissues. However, some patients are not eligible for the treatment as...

A study conducted by the researchers at the Brigham and Women's Hospital has discovered that cancer cells always disable the immune cells that attack them. The study was conducted by using nanotechnology research infrastructure, which has been funded by the U.S National Science Foundation. The...

Jennifer M. Scalici was awarded the 2021 Mayer Mitchell Award for Excellence in Cancer Research on Friday for her research on ovarian cancer carcinogenesis and chemo-prevention. Scalici, chief of gynecologic oncology service at the USA Health Mitchell Cancer Institute and a professor of gynecologic...

A clinical trial on children's cancer has revealed that a combination of all-trans retinoic acid, which is a metabolite of vitamin A, and arsenic trioxide is found to be very effective in curing children suffering from standard-and high-risk acute promyelocytic leukaemia, or APL. Almost all the...

A study conducted by the University of Gothenburg has revealed that the correct amount of glucose levels is necessary for reducing the cancer risk in obesity and type 2 diabetes. Weight loss on a large scale does offer protection against cancer but if the glucose levels are under proper control, the...

A study led by co-first authors, Dr. Prashant Thakkar and Dr. Katsuhiro Kita, former postdocs at Weill Cornell Medicine has come forward with the knowledge of a new protein variant that is responsible for gastric cancers to resist a generally effective family of chemotherapy drugs. Published...

A new drug has taken the world of metastatic breast cancer by storm after reports of a chemical compound showing a 95-100% success rate against the cancer cells in animals surfaced. Experts believe that the compound may well be on its way to human trials. ErSO, a new drug developed by researchers...

Pancreatic cancer is known to be one of the most aggressive forms of cancer and has very vague symptoms. This form of cancer is usually detected in its last stages and by that time, it becomes too late for any kind of treatment as it would have spread all over the body. At present, pancreatic cancer...

Very often, there is lot of confusion between moles and melanomas as both are considered as skin cancers. That is not correct even though both have the same origin known as melanocytes. That is where the similarity ends as while moles are mostly considered to be harmless, melanomas are cancerous and...

Pancreatic cancer is considered to be one of the fatal and most difficult cancers to treat as the variant has a 5-year survival rate of just 5%. This is primarily due to a lack of proper prognosis of the disease, which leads to a more vicious metastasis period infecting other parts of the body. ...

One of the most effective methods of cancer treatment is chemotherapy, but it has serious side effects on the human body. In a bid to reduce the intensity of these side effects, scientists are looking at ways to bring the drugs directly to the cancer cells so that people do not have to suffer the serious...

A new report suggests that the people who have suffered from cancer in their childhood will suffer from greater physical ailments. According to a report published in The Lancet Regional Health-Europe, the risk varies between different types of cancer. These patients have to make 5 times as many hospital...

The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded grants to the Harold C. Simmons Comprehensive Cancer Research Center on November 19. The grant is aimed at increasing minority participation in trials, developing drugs to battle brain tumors, and increasing the research...

Follow RTT